Common use of Compliance with Nasdaq Continued Listing Requirements Clause in Contracts

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq SmallCap Market continued listing requirements. There are no proceedings pending or, to the Company's knowledge, threatened against the Company relating to the continued listing of the Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 6 contracts

Samples: Common Stock Purchase Agreement (Peregrine Pharmaceuticals Inc), Common Stock Purchase Agreement (Peregrine Pharmaceuticals Inc), Common Stock Purchase Agreement (Peregrine Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable Nasdaq SmallCap Market continued listing requirements. There Except as provided in Schedule 4.19, there are no proceedings pending or, or to the Company's knowledge, Knowledge threatened against the Company relating to the continued listing of the Company's Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge Knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 2 contracts

Samples: Debenture and Warrant Purchase Agreement (Antares Pharma Inc), Debenture and Warrant Purchase Agreement (Antares Pharma Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq SmallCap Market continued listing requirements. There are no proceedings pending or, to the Company's knowledge, or threatened against the Company relating to the continued listing of the Company’s Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Imcor Pharmaceutical Co), Securities Purchase Agreement (Imcor Pharmaceutical Co)

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable Nasdaq SmallCap Market continued listing requirementsrequirements for the Nasdaq Stock Market and is listed in good standing on the Nasdaq Stock Market. There are no proceedings pending or, to the Company's knowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on the Nasdaq SmallCap Stock Market and the Company has not received any currently effective notice of, nor to the Company's knowledge of the Company is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Stock Market.

Appears in 2 contracts

Samples: Purchase Agreement (Avi Biopharma Inc), Purchase Agreement (Avi Biopharma Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq SmallCap National Market continued listing requirements. There are no proceedings pending or, to the Company's knowledgeKnowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on the Nasdaq SmallCap National Market and the Company has not received any currently effective notice of, nor to the Company's knowledge Knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap National Market.

Appears in 2 contracts

Samples: Purchase Agreement (Artisoft Inc), Purchase Agreement (Artisoft Inc)

Compliance with Nasdaq Continued Listing Requirements. The Except as disclosed in the SEC Filings, the Company is in compliance with applicable Nasdaq SmallCap Market continued listing requirements. There are no proceedings pending or, to the Company's knowledgeKnowledge, threatened against the Company relating to the continued listing of the Company's Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge Knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 1 contract

Samples: Purchase Agreement (Goamerica Inc)

AutoNDA by SimpleDocs

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with all applicable Nasdaq SmallCap Market continued listing requirementsrequirements and is in good standing on such exchange. There are no proceedings pending or, or to the Company's knowledge, knowledge threatened against the Company relating to the continued listing of the Company's Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge of the Company is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 1 contract

Samples: Purchase Agreement (Alpnet Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq SmallCap Market continued listing requirements. There are no proceedings pending or, to the Company's knowledge, or threatened against the Company relating to the continued listing of 10 the Company's Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 1 contract

Samples: Registration Rights Agreement (Photogen Technologies Inc)

Compliance with Nasdaq Continued Listing Requirements. The Company is in compliance with applicable Nasdaq SmallCap Market continued listing requirements. There are no proceedings pending or, to the Company's ’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on the Nasdaq SmallCap Market and the Company has not received any currently effective notice of, nor to the Company's ’s knowledge is there any basis for, the delisting of the Common Stock from the Nasdaq SmallCap Market.

Appears in 1 contract

Samples: Common Stock Purchase Agreement (Peregrine Pharmaceuticals Inc)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!